Bunge Limited
BG
$118.71
-1.17%
Bunge Global SA is a leading global agribusiness and food company that connects farmers to consumers, operating across the entire value chain from sourcing and processing oilseeds to merchandising grains and producing food, feed, and fuel. As one of the world's largest oilseed processors and a key player in agricultural supply chains, Bunge holds a distinct competitive position through its integrated global network, scale, and expertise in logistics and risk management. The current investor narrative centers on Bunge's ambitious long-term growth strategy, highlighted by its recent announcement of a $15 mid-cycle EPS target by 2030, which signals confidence in future earnings power despite near-term headwinds from volatile commodity markets and compressed processing margins. The stock is also drawing attention for its shareholder return program and its role in the global food security and renewable fuels themes.…
BG
Bunge Limited
$118.71
Related headlines
Investment Opinion: Should I buy BG Today?
Based on the analysis, BG is rated a Buy. The stock offers a compelling risk-reward profile with a forward P/E of 10.47x, which is attractive for a company with Bunge's global scale and growth potential. The average analyst target of $141.22 implies an upside of approximately 19% from the current price, and the company's 2030 EPS target of $15 suggests significant earnings growth ahead. The dividend yield of 3.12% provides additional return potential.
Sign up to view all
BG 12-Month Price Forecast
The AI assessment is bullish on BG over the next 12 months, driven by the attractive forward valuation and positive analyst sentiment. The company's 2030 EPS target of $15 provides a clear growth narrative, and the low beta makes it a defensive play in a volatile market. However, the thin margins and high debt levels warrant caution. If the company can demonstrate margin improvement in the next few quarters, the stock is likely to re-rate higher. Conversely, if margins remain depressed, the stock could underperform. The AI stance would be upgraded to high confidence if the company beats earnings estimates and raises guidance.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Bunge Limited's 12-month outlook, with a consensus price target around $141.22 and implied upside of +19.0% versus the current price.
Average Target
$141.22
0 analysts
Implied Upside
+19.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$116 - $150
Analyst target range
The target price range spans from a low of $116.00 to a high of $150.00, indicating a spread of $34.00 or about 24% of the average target. The high target of $150.00 assumes that Bunge will successfully execute its 2030 strategy, achieve its $15 mid-cycle EPS goal, and benefit from a recovery in agricultural commodity markets and processing margins. The low target of $116.00, which is slightly below the current price, suggests that some analysts see downside risks from continued margin compression, volatile commodity prices, or potential operational setbacks. The relatively wide range reflects the inherent uncertainty in agricultural markets and the cyclicality of Bunge's earnings. Recent ratings have been consistently positive, with no downgrades or negative actions in the past six months, indicating that analyst sentiment remains constructive on the stock's long-term prospects.
Bulls vs Bears: BG Investment Factors
Bunge presents a mixed picture: strong long-term momentum and an ambitious growth strategy are offset by extremely thin margins and high earnings volatility. The bull case rests on the company's ability to execute its 2030 plan and achieve the $15 EPS target, which would justify the current valuation and drive further upside. The bear case highlights the cyclicality of agricultural markets and the risk of continued margin compression, which could lead to earnings disappointments. Currently, the evidence slightly favors the bull case given the low forward P/E and positive analyst sentiment, but the key tension lies in whether Bunge can translate its scale and strategic initiatives into sustainable earnings growth. If margins remain depressed, the stock could face significant downside, but if the company achieves its targets, the upside is substantial.
Bullish
- Strong 1-Year Price Performance: BG stock has surged 46.32% over the past year, significantly outperforming the S&P 500's 18.65% gain. This demonstrates strong market confidence and momentum, supported by a 28.14% year-to-date increase.
- Attractive Forward Valuation: With a forward P/E of 10.47x versus a trailing P/E of 17.96x, the market anticipates substantial earnings growth. This low forward multiple suggests the stock is undervalued relative to its expected earnings power, especially given the company's global scale.
- Ambitious 2030 EPS Target: Management has set a $15 mid-cycle EPS target by 2030, signaling confidence in long-term earnings growth. This target, if achieved, would represent a significant increase from current levels and supports the bullish case for the stock.
- Positive Analyst Sentiment: Analyst ratings have been consistently positive with no downgrades in the past six months. The average price target of $141.22 implies an upside of approximately 19% from the current price of $118.71, with a high target of $150.00.
Bearish
- Extremely Low Profitability: Net margin is a razor-thin 1.16%, and the most recent quarter (Q1 2026) saw net income of only $68 million on revenue of $21.861 billion, a net margin of just 0.31%. This highlights the company's vulnerability to margin compression and commodity price volatility.
- Revenue Volatility: Revenue has been highly erratic, swinging from $11.643 billion in Q1 2025 to $23.760 billion in Q4 2025, a 104% increase, and then to $21.861 billion in Q1 2026. This lumpiness makes earnings difficult to predict and can lead to negative surprises.
- High Debt Levels: The debt-to-equity ratio stands at 0.997, indicating that debt is nearly equal to equity. This high leverage increases financial risk, especially in a cyclical industry where cash flows can be unpredictable.
- Underperformance in Recent Months: Despite the strong 1-year performance, BG has declined 6.13% over the past 3 months and has underperformed the S&P 500 by 10.56% over that period. This suggests waning momentum and potential headwinds.
BG Technical Analysis
Bunge's stock has demonstrated a robust long-term uptrend, with a 1-year price change of +46.32%, significantly outperforming the S&P 500's +18.65% over the same period. The current price of $118.71 sits at approximately 76% of the 52-week range (low: $76.01, high: $134.87), indicating the stock is in the upper half of its yearly range but has pulled back from its highs. This positioning suggests the market has rewarded the stock strongly over the past year, yet the recent retreat from the peak implies a period of consolidation or profit-taking after a substantial run.
Beta
0.66
0.66x market volatility
Max Drawdown
-20.2%
Largest decline past year
52-Week Range
$76-$135
Price range past year
Annual Return
+46.3%
Cumulative gain past year
| Period | BG Return | S&P 500 |
|---|---|---|
| 1m | +11.3% | -0.4% |
| 3m | -6.1% | +4.2% |
| 6m | +1.7% | +13.7% |
| 1y | +46.3% | +19.0% |
| ytd | +28.1% | +12.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BG Fundamental Analysis
Bunge's revenue trajectory has been highly volatile, with the most recent quarter (Q1 2026) reporting revenue of $21.861 billion, a substantial 87.76% year-over-year increase from $11.643 billion in Q1 2025. However, this growth is not consistent across quarters; for instance, Q2 2025 revenue was $12.769 billion, Q3 2025 was $22.153 billion, and Q4 2025 was $23.760 billion, reflecting the lumpy nature of agricultural commodity trading and processing. The multi-quarter trend shows a sharp acceleration in the most recent quarter, but this is likely driven by commodity price movements and trading gains rather than organic volume growth. The company's revenue is heavily dependent on global agricultural cycles, trade flows, and energy prices, making it inherently cyclical and difficult to project linearly.
Quarterly Revenue
$21.9B
2026-03
Revenue YoY Growth
+87.8%
YoY Comparison
Gross Margin
3.5%
Latest Quarter
Free Cash Flow
$14000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BG Overvalued?
Given that Bunge's trailing twelve-month net income is positive (with Q1 2026 net income of $68 million), the most appropriate primary valuation metric is the price-to-earnings (PE) ratio. The trailing PE stands at 17.96x, while the forward PE is 10.47x, indicating that the market expects a significant increase in earnings over the next year. This gap between trailing and forward multiples implies that analysts anticipate a strong earnings recovery, likely driven by improved processing margins and the company's strategic initiatives. The forward PE of 10.47x is relatively low for a company with Bunge's global scale and growth prospects, suggesting the stock may be undervalued if the earnings forecast is met.
PE
18.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 4x~24x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant for Bunge. The company's net margin is extremely thin at 1.16%, and the most recent quarter saw a net margin of just 0.31%, indicating that even small changes in commodity prices or processing costs can have a disproportionate impact on profitability. The debt-to-equity ratio of 0.997 is high, and with interest expenses of $181 million in Q1 2026, the company is exposed to rising interest rates. Revenue is highly volatile, with quarterly swings of over 100% year-over-year, making it difficult to forecast earnings and cash flows. Free cash flow is minimal at $14 million TTM, which limits financial flexibility.
FAQ
The key risks of holding BG include: 1) Financial risk: High debt levels (debt-to-equity of 0.997) and thin net margins (1.16%) make the company vulnerable to interest rate hikes and margin compression. 2) Market risk: The cyclical nature of agricultural commodities can lead to volatile earnings, as seen in the revenue swings over the past year. 3) Competitive risk: Intense competition from other agribusiness giants could pressure margins. 4) Macro risk: Trade policies, weather conditions, and global economic slowdowns can impact demand and supply. The most severe risk is a prolonged period of low processing margins, which could lead to a decline in the stock price to the 52-week low of $76.01.
The 12-month forecast for BG is moderately bullish. In the base case (50% probability), the stock is expected to trade in the range of $125-$135, driven by stable earnings and gradual progress toward the 2030 targets. In the bull case (30% probability), the stock could reach $135-$150 if the company exceeds expectations and margins improve. In the bear case (20% probability), the stock could decline to $105-$116 if margins remain depressed and earnings disappoint. The most likely scenario is the base case, with the stock moving towards the analyst average target of $141.22, implying an upside of about 19%.
Based on the valuation metrics, BG appears undervalued. The forward P/E of 10.47x is significantly lower than the trailing P/E of 17.96x, indicating that the market expects earnings to grow substantially. The price-to-book ratio of 0.92 suggests that the stock is trading below its book value, which is rare for a company of Bunge's size. Additionally, the price-to-sales ratio of 0.21 is very low, reflecting the low margins but also suggesting that the market is not paying a premium for revenue. Overall, the valuation implies that the market is skeptical of Bunge's ability to achieve its growth targets, but if the company executes, the stock could re-rate higher.
BG appears to be a good buy for investors with a long-term horizon and a tolerance for cyclicality. The stock trades at a forward P/E of 10.47x, which is attractive given the expected earnings growth, and the analyst average target of $141.22 implies an upside of about 19% from the current price. However, the company's thin margins and high debt levels pose risks, and the stock could be volatile in the short term. For investors seeking a value play in the agribusiness sector with a dividend yield of 3.12%, BG could be a suitable addition to a diversified portfolio.
BG is more suitable for long-term investment due to its cyclical nature and the time required for the company's strategic initiatives to bear fruit. The stock's beta of 0.66 indicates lower volatility than the market, making it a relatively stable holding, but short-term price movements can be unpredictable due to commodity price swings. The company's 2030 EPS target of $15 suggests that the market will reward patient investors who hold through the cycles. A minimum holding period of 3-5 years is recommended to allow the company to execute its growth strategy and for the earnings to materialize. For short-term traders, the stock may offer opportunities around earnings announcements, but the risk is higher.